![Mark Lappe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Lappe
Plus aucun poste en cours
Fortune : 96 M $ au 31/05/2026
Profil
Mark Paul Lappe is the founder of Lappe & Associates, Inc. (1990).
Mr. Lappe is the founder of Efficacy Capital LLC (2004).
Mr. Lappe is the founder of Inhibrx LP (2010).
Mr. Lappe is the founder of Sanofi AATD, Inc. (2010).
Mr. Lappe is also the founder of Efficacy Biotech Fund LP.
Mr. Lappe is currently the Chairman & Chief Executive Officer at Inhibrx Biosciences, Inc. since 2025.
Mr. Lappe is currently the Managing Partner at Efficacy Capital Ltd. since 2003.
Formerly, Mr. Lappe served as Chairman at Repros Therapeutics, Inc. from 2008 to 2009.
Mr. Lappe served as Non-Executive Director at Osmetech Ltd. in 2009.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
6,31 % | 07/04/2026 | 925 413 ( 6,31 % ) | 96 M $ | 31/05/2026 |
Postes actifs de Mark Lappe
| Sociétés | Poste | Début |
|---|---|---|
Efficacy Capital Ltd. | Corporate Officer/Principal | 10/06/2009 |
Anciens postes connus de Mark Lappe
| Sociétés | Poste | Fin |
|---|---|---|
| INHIBRX, INC. | Directeur Général | 30/05/2024 |
| REPROS THERAPEUTICS INC | Président | 12/11/2009 |
Osmetech Ltd.
 Osmetech Ltd. Medical/Nursing ServicesHealth Services Design, development, manufacture and sale of molecular diagnostics instruments and consumables enabling | Directeur/Membre du Conseil | 28/08/2009 |
Efficacy Biotech Fund LP | Fondateur | - |
Inhibrx LP
 Inhibrx LP BiotechnologyHealth Technology Develops therapeutic antibodies and pharmaceuticals | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat hormonal and reproductive system disorders | Health Technology |
Efficacy Capital Ltd. | |
Efficacy Biotech Fund LP | |
Osmetech Ltd.
Osmetech Ltd. Medical/Nursing ServicesHealth Services Design, development, manufacture and sale of molecular diagnostics instruments and consumables enabling | Health Services |
Lappe & Associates, Inc. | |
Efficacy Capital LLC
 Efficacy Capital LLC Investment ManagersFinance Efficacy Capital invests in US publicly-traded stocks and in fixed-income securities. The firm invests mainly in companies operating in the biotechnology and pharmaceutical industries. | Finance |
Inhibrx LP
Inhibrx LP BiotechnologyHealth Technology Develops therapeutic antibodies and pharmaceuticals | Health Technology |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
